Reasons for Lack of Referral to Medical Oncology for Systemic Therapy in Stage IV Non-Small-Cell Lung Cancer: Comparison of 2003–2006 With 2010–2011

Current Oncology - Canada
doi 10.3747/co.24.3691
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

P2.01-023 Reasons for Withholding Systemic Therapy in Stage IV NSCLC: Comparison of Years 2004 to 2007 and 2010 to 2013

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Image Features for the Future in Stage IV Non-Small Cell Lung Cancer

English

Molecular Testing for Stage IV Non–Small Cell Lung Cancer Patients With Targetable Mutations Following Disease Progression

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Advances in Immune Therapy for Non Small Cell Lung Cancer

Medical Diagnosis
2016English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

The Impact of Rescue or Maintenance Therapy With EGFR TKIs for Stage IIIb-IV Non-Squamous Non-Small-Cell Lung Cancer Patients Requiring Mechanical Ventilation

BMC Anesthesiology
AnesthesiologyPain Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy